729. Should We Replace Tuberculin Skin Tests (TSTs) with Interferon Gamma Release Assays (IGRAs)? YES
Session: Interactive Session: Clinical Controversies in Infectious Diseases
Friday, October 21, 2011: 2:55 PM
Room: Grand Ballroom (East-West)


L. Masae Kawamura, MD, San Francisco Department of Public Health, San Francisco, CA

L. Masae Kawamura, MD has been a tuberculosis (TB) clinician for more than 20 years, serving as Director of San Francisco’s TB Control Program since 1996. Under her leadership, San Francisco became the first jurisdiction in the U.S. to implement Interferon gamma release assay (IGRA) blood testing for TB. Currently, TB Control is also participating in studies preliminary to acceptance of the new sputum-sample based GeneXpert TB test, from Cepheid. A Co-Principal Investigator for Curry National TB Center, a CDC–affiliated Regional Training and Medical Consultation Center, Dr. Kawamura has served on the faculty since its inception in 1994. She also served on the CDC Advisory Council for the Elimination of TB (ACET) for eight years, the last three as chair, and continues to serve on subcommittees of the group. Recently Dr. Kawamura completed a term as president of the North American Chapter or the International Union Against Tuberculosis and Lung Disease (The Union). Dr. Kawamura is an assistant clinical professor at the University of California–San Francisco (UCSF) and has coauthored numerous TB publications.



Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.